SWK HOLDINGS CORPORATION (OTCMKTS:SWKH) Files An 8-K Other Events
Item 8.01. Other Events
Holmdel Pharmaceuticals LP Sale of InnoPran XL
On February 23, 2017, Holmdel Pharmaceuticals, LP sold
substantially all of its assets, which primarily included the
U.S. marketing authorization rights to InnoPran XL to ANI
Pharmaceuticals, Inc. SWK HP Holdings GP LLC, a wholly-owned
subsidiary of SWK Holdings Corporation, received net proceeds
from the transaction of approximately $8.0 million.
About SWK HOLDINGS CORPORATION (OTCMKTS:SWKH)
SWK Holdings Corporation is a healthcare capital provider. The Company offers financing solutions to a range of life science companies, institutions and inventors. The Company’s focus is on monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. The Company, through its subsidiary SWK Advisors LLC, provides non-discretionary investment advisory services to institutional clients in separately managed accounts to similarly invest in life science finance. It focuses to fund transactions through its own working capital, as well as by building its asset management business by raising additional third party capital to be invested alongside its capital. The Company evaluates and invests in a range of healthcare related companies and products. SWK HOLDINGS CORPORATION (OTCMKTS:SWKH) Recent Trading Information
SWK HOLDINGS CORPORATION (OTCMKTS:SWKH) closed its last trading session up +0.49 at 10.48 with 200 shares trading hands.
